Production (Stage)
Heron Therapeutics, Inc.
HRTX
$2.12
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.68M | 59.28M | 70.89M | 67.35M | 71.52M |
| Total Receivables | 78.74M | 78.88M | 67.04M | 73.71M | 65.32M |
| Inventory | 56.93M | 53.16M | 45.95M | 42.86M | 42.47M |
| Prepaid Expenses | 26.49M | 17.69M | 11.31M | 7.25M | 6.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 212.84M | 209.01M | 195.19M | 191.17M | 185.90M |
|
|
|||||
| Total Current Assets | 212.84M | 209.01M | 195.19M | 191.17M | 185.90M |
| Net Property, Plant & Equipment | 16.63M | 17.65M | 18.88M | 20.04M | 24.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.28M | 6.48M | 6.71M | 6.93M | 7.88M |
| Total Assets | 235.75M | 233.15M | 220.78M | 218.14M | 217.89M |
|
|
|||||
| Total Accounts Payable | 12.33M | 11.71M | 10.19M | 10.23M | 837.00K |
| Total Accrued Expenses | 69.77M | 76.71M | 37.22M | 29.88M | 32.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.29M | 3.04M | 3.25M | 3.19M | 3.14M |
| Total Finance Division Other Current Liabilities | 4.16M | -- | 34.88M | 37.02M | 38.67M |
| Total Other Current Liabilities | 4.16M | -- | 34.88M | 37.02M | 38.67M |
| Total Current Liabilities | 88.56M | 91.46M | 85.54M | 80.32M | 75.38M |
|
|
|||||
| Total Current Liabilities | 88.56M | 91.46M | 85.54M | 80.32M | 75.38M |
| Long-Term Debt | 174.97M | 174.73M | 174.48M | 174.23M | 173.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 522.00K | 1.29M | 2.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 682.00K | 615.00K | 241.00K | 241.00K | 241.00K |
| Total Liabilities | 264.21M | 266.80M | 260.78M | 256.08M | 251.65M |
|
|
|||||
| Common Stock & APIC | 1.89B | 1.89B | 1.88B | 1.88B | 1.88B |
| Retained Earnings | -1.92B | -1.92B | -1.92B | -1.92B | -1.91B |
| Treasury Stock & Other | 1.00K | 13.00K | 40.00K | -8.00K | -6.00K |
| Total Common Equity | -28.45M | -33.65M | -40.01M | -37.94M | -33.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -28.45M | -33.65M | -40.01M | -37.94M | -33.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -28.45M | -33.65M | -40.01M | -37.94M | -33.77M |
|
|
|||||